Basel, Switzerland

Ian D Chapman

This inventor holds 1 USPTO granted patent. Top assignee: Sandoz Gmbh. Active years: 1991.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ian D Chapman: Innovator in Pharmaceutical Chemistry

Introduction

Ian D Chapman is a notable inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that address various health issues. His work has led to the creation of innovative solutions for treating conditions such as high blood pressure and respiratory disorders.

Latest Patents

Ian D Chapman holds a patent for "Pharmaceutically useful benzo(.beta.)pyranes and pyranopyridines." This patent describes new benz[b]pyranes and pyranopyridines of a specific formula, which are useful in treating raised blood pressure, vascular disorders, hair loss, asthma, and other obstructive respiratory conditions. The compounds also include novel pharmaceutical compositions that act as K+ channel activators, suitable for therapeutic use.

Career Highlights

Ian D Chapman is currently associated with Sandoz GmbH, a leading global healthcare company. His work at Sandoz has allowed him to focus on developing innovative pharmaceutical solutions that improve patient outcomes. With a patent portfolio that includes 1 patent, he continues to contribute to advancements in medical science.

Collaborations

Throughout his career, Ian has collaborated with esteemed colleagues such as John Morley and Stefan Blarer. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical products.

Conclusion

Ian D Chapman is a distinguished inventor whose work in pharmaceutical chemistry has made a significant impact on healthcare. His innovative patents and collaborations highlight his commitment to improving treatments for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…